Abstract
The role of the newly discovered cysteine protease, cathepsin K, in osteoporosis and rheumatoid arthritis is reviewed. The current development of cathepsin K inhibitors and their targeted delivery using synthetic polymer carriers are discussed. Future challenges and possible strategies to improve these delivery systems are addressed.
Original language | English (US) |
---|---|
Pages (from-to) | 73-79 |
Number of pages | 7 |
Journal | International journal of pharmaceutics |
Volume | 277 |
Issue number | 1-2 |
DOIs | |
State | Published - Jun 11 2004 |
Externally published | Yes |
Keywords
- Antiresorptive
- Cathepsin K
- Inhibitor-polymer conjugates
- Resorption lacuna
- Semitelechelic HPMA polymer
- mPEG
ASJC Scopus subject areas
- Pharmaceutical Science